Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study. (Q53446914)
Jump to navigation
Jump to search
scientific article published in January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study. |
scientific article published in January 2013 |
Statements
Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study. (English)
Jaren W Landen
Qinying Zhao
Sharon Cohen
Michael Borrie
Michael Woodward
Clare B Billing
Kelly Bales
Christine Alvey
Fred McCush
Jerry Yang
James W Kupiec
Martin M Bednar
1 January 2013
36
1
14-23